COVID-19 in a pediatric patient with Glanzmann thrombasthenia

Pediatr Blood Cancer. 2020 Oct;67(10):e28662. doi: 10.1002/pbc.28662. Epub 2020 Aug 15.

Authors

Laurent Sattler¹, Olivier Feugeas², Claire Hager³, Lélia Grunebaum¹, Dominique Desprez²

Affiliations

¹ Laboratoire d'Hématologie, Unité Hémostase, Hôpitaux universitaires de Strasbourg, Strasbourg, France.
² Centre de Ressource et Compétence des Maladies Hémorragiques Constitutionnelles, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
³ Service de Néonatologie, Hôpitaux universitaires de Strasbourg, Strasbourg, France.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Amoxicillin / therapeutic use
Anti-Bacterial Agents / therapeutic use
C-Reactive Protein / analysis
COVID-19 / complications*
COVID-19 / diagnosis*
COVID-19 Drug Treatment
Computed Tomography Angiography
Enoxaparin / therapeutic use
Feces / virology
Female
Fibrin Fibrinogen Degradation Products / analysis
Hematologic Agents / therapeutic use
Hospitalization
Humans
Menorrhagia / complications
SARS-CoV-2 / isolation & purification
Thorax / diagnostic imaging
Thrombasthenia / complications*
Thrombasthenia / drug therapy
Treatment Outcome

Substances

Anti-Bacterial Agents
Enoxaparin
Fibrin Fibrinogen Degradation Products
Hematologic Agents
fibrin fragment D
Amoxicillin
C-Reactive Protein